Sulforhodamine B colorimetric assay for cytotoxicity screening.
about
Methylseleninic acid enhances paclitaxel efficacy for the treatment of triple-negative breast cancerMolecular characterization, expression analysis, and role of ALDH3B1 in the cellular protection against oxidative stressA novel small molecule hydroxamate preferentially inhibits HDAC6 activity and tumour growthSmall-Molecule Bcl2 BH4 Antagonist for Lung Cancer TherapyCOA6 is a mitochondrial complex IV assembly factor critical for biogenesis of mtDNA-encoded COX2Fatty Acid Composition of Tissue Cultured Breast Carcinoma and the Effect of Stearoyl-CoA Desaturase 1 InhibitionElisidepsin Interacts Directly with Glycosylceramides in the Plasma Membrane of Tumor Cells to Induce Necrotic Cell DeathProfiling animal toxicants by automatically mining public bioassay data: a big data approach for computational toxicologyHigh throughput ratio imaging to profile caspase activity: potential application in multiparameter high content apoptosis analysis and drug screeningMechanical properties of growing melanocytic nevi and the progression to melanomaIrvalec inserts into the plasma membrane causing rapid loss of integrity and necrotic cell death in tumor cellsmTOR-independent 4E-BP1 phosphorylation is associated with cancer resistance to mTOR kinase inhibitors.AZD1480 blocks growth and tumorigenesis of RET- activated thyroid cancer cell linesProcaspase-3 activation as an anti-cancer strategy: structure-activity relationship of procaspase-activating compound 1 (PAC-1) and its cellular co-localization with caspase-3Hepatocyte differentiation of human induced pluripotent stem cells is modulated by stearoyl-CoA desaturase 1 activityDiscovery and canine preclinical assessment of a nontoxic procaspase-3-activating compoundZnO nanoparticles augment ALT, AST, ALP and LDH expressions in C2C12 cellsIndole trimers with antibacterial activity against Gram-positive organisms produced using combinatorial biocatalysisIron labeling and pre-clinical MRI visualization of therapeutic human neural stem cells in a murine glioma modelNoscapine induced apoptosis via downregulation of survivin in human neuroblastoma cells having wild type or null p53p53 modulation as a therapeutic strategy in gastrointestinal stromal tumorsSTAT3 negatively regulates thyroid tumorigenesisHypoxia-induced cytotoxic drug resistance in osteosarcoma is independent of HIF-1AlphaMethylseleninic acid sensitizes Notch3-activated OVCA429 ovarian cancer cells to carboplatinPreclinical assessment of carboplatin treatment efficacy in lung cancer by 18F-ICMT-11-positron emission tomographyMitochondrial-targeted curcuminoids: a strategy to enhance bioavailability and anticancer efficacy of curcuminGene Expression Profiling of H9c2 Myoblast Differentiation towards a Cardiac-Like PhenotypeCurcumin induces apoptosis of upper aerodigestive tract cancer cells by targeting multiple pathwaysTargeting the NF-κB Pathway as a Combination Therapy for Advanced Thyroid CancerTargeting Rapamycin to Podocytes Using a Vascular Cell Adhesion Molecule-1 (VCAM-1)-Harnessed SAINT-Based Lipid Carrier SystemPleiotropic Anti-Angiogenic and Anti-Oncogenic Activities of the Novel Mithralog Demycarosyl-3D-ß-D-Digitoxosyl-Mithramycin SK (EC-8042)Phosphatidylinositol 3-Kinase/AKT Pathway Inhibition by Doxazosin Promotes Glioblastoma Cells Death, Upregulation of p53 and Triggers Low NeurotoxicityNovel Promising Estrogenic Receptor Modulators: Cytotoxic and Estrogenic Activity of Benzanilides and DithiobenzanilidesNovel small-molecule PGC-1α transcriptional regulator with beneficial effects on diabetic db/db miceActivation of the ATR kinase by the RPA-binding protein ETAA1Growth-Inhibiting Activity of Resveratrol Imine Analogs on Tumor Cells In VitroChemical Swarming: Depending on Concentration, an Amphiphilic Ruthenium Polypyridyl Complex Induces Cell Death via Two Different MechanismsIdentification of selective inhibitors of RET and comparison with current clinical candidates through development and validation of a robust screening cascade.Casitas B-lineage lymphoma linker helix mutations found in myeloproliferative neoplasms affect conformationElimination of Cancer Stem-Like Cells and Potentiation of Temozolomide Sensitivity by Honokiol in Glioblastoma Multiforme Cells
P2860
Q21134780-BC30D683-D9F5-4793-810F-97410B04527AQ24294878-B95CFDC9-7513-4B12-A8C4-8701404AB62CQ24309277-38FEEF87-3EE6-4604-86A6-216AE74C5428Q24337757-DF149A36-855C-432F-9796-08EF19F87060Q24338334-2D52F321-F0D3-4E1F-98B7-DE10A63D58A0Q24562890-30A4D46D-E3A2-44D6-AD6D-AC1D69513807Q27312540-46CCF290-441D-483C-8F8F-E689EEDE4AB8Q27323553-1E089DB6-A206-4F1A-95BF-8CE4102DC8E2Q27339765-86A81E35-618A-4428-B64A-E03882D20226Q27342765-3B6DF017-3141-4641-9A4B-E1295A23DC52Q27346446-7C5BAF24-2810-41C2-89D8-1FB201C8DB95Q27851707-E6FD5701-BD50-4739-A3B6-E5D487CFAA1DQ27851932-D471F39A-DA2A-4099-A71E-E760E840D75CQ28256422-98F761E5-1846-46B0-AF6D-552888333F46Q28271141-C17ADBBE-CCFD-49C7-8460-043714100551Q28292596-4998D6CC-7955-443E-A124-49BC8A014465Q28392517-C8CCF3D2-1FDA-4E7D-B679-8D71CB4D61A8Q28397152-DFEB5A17-5CF4-41D3-8D47-EDD3948B91D8Q28476235-861E335A-6E25-46B1-A73F-2D9978B4A0D4Q28481583-C6C362D7-006E-49F1-AD12-3FF057A9ADA1Q28483922-04F7C297-92A6-4BB6-BC22-862B7D35C732Q28505424-9740ED53-A50F-4874-880E-7E4DD7A9BF3CQ28533909-29D65663-D183-46B4-9D06-D0197CA828C8Q28540634-5D973D19-CE85-421A-BEAD-B65212A0C780Q28540769-9463D14C-3EFB-41EB-BFA4-B54BFB4194D0Q28540774-5065588E-CAE6-4CEE-8F7B-8C7E53119E2BQ28545881-6E82607C-D6E5-4CF8-8450-32FB0B135CCAQ28546708-369127CA-57C3-432A-81E6-B0CF3B75F6B8Q28547158-47142C57-4B3D-4E46-9238-4BA88CA2EB0DQ28548472-30D7AC95-D1DE-4434-BE8A-F5FC87893105Q28550699-51E9F1FB-3CF3-4997-A224-7D1F44DF9970Q28551654-DCC82863-30BB-48B9-87C3-8B931A5D045BQ28552026-97111D6C-071B-4B41-BA7E-F52C804F1655Q28582239-555453BE-8073-4959-B5BF-34F4795A6DBCQ28596569-F1A012A8-05EB-4CFB-A78E-64ADF2B95941Q28818518-829574A7-12EF-4EB8-BEBC-22984D4069E9Q28822145-12FA6A86-7D0B-4B24-A47B-B8142F9D96D7Q28830947-7BDDDDFB-9760-4B50-B086-D4CC284B8628Q28831057-71E8A7F2-3465-438C-8A94-433B7CFA6231Q30048454-AE60838E-5B6E-4CE6-BF31-BF5D29BF067C
P2860
Sulforhodamine B colorimetric assay for cytotoxicity screening.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Sulforhodamine B colorimetric assay for cytotoxicity screening.
@en
Sulforhodamine B colorimetric assay for cytotoxicity screening.
@nl
type
label
Sulforhodamine B colorimetric assay for cytotoxicity screening.
@en
Sulforhodamine B colorimetric assay for cytotoxicity screening.
@nl
prefLabel
Sulforhodamine B colorimetric assay for cytotoxicity screening.
@en
Sulforhodamine B colorimetric assay for cytotoxicity screening.
@nl
P356
P1433
P1476
Sulforhodamine B colorimetric assay for cytotoxicity screening.
@en
P2093
Kanyawim Kirtikara
Vanicha Vichai
P2888
P304
P356
10.1038/NPROT.2006.179
P577
2006-01-01T00:00:00Z